These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32735966)

  • 1. Assessing the risk of adalimumab use for hidradenitis suppurativa during the COVID-19 pandemic.
    Kearns DG; Chat VS; Uppal S; Wu JJ
    J Am Acad Dermatol; 2020 Dec; 83(6):e433-e434. PubMed ID: 32735966
    [No Abstract]   [Full Text] [Related]  

  • 2. Adalimumab for treatment of hidradenitis suppurativa during the COVID-19 pandemic: Safety considerations.
    Blaszczak A; Trinidad JCL; Cartron AM
    J Am Acad Dermatol; 2020 Jul; 83(1):e31. PubMed ID: 32283230
    [No Abstract]   [Full Text] [Related]  

  • 3. Remote management of hidradenitis suppurativa in a pandemic era of COVID-19.
    Kang NC; Hsiao J; Shi V; Naik HB; Lowes MA; Alavi A
    Int J Dermatol; 2020 Sep; 59(9):e318-e320. PubMed ID: 32578210
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessing the risk of dupilumab use for atopic dermatitis during the COVID-19 pandemic.
    Kearns DG; Uppal S; Chat VS; Wu JJ
    J Am Acad Dermatol; 2020 Sep; 83(3):e251-e252. PubMed ID: 32534081
    [No Abstract]   [Full Text] [Related]  

  • 5. Global Hidradenitis Suppurativa COVID-19 Registry: a registry to inform data-driven management practices.
    Naik HB; Alhusayen R; Frew J; Guilbault S; Ingram JR; Lowes MA; Marzano AV; Paul M; Villumsen B; Yannuzzi CA
    Br J Dermatol; 2020 Oct; 183(4):780-781. PubMed ID: 32597495
    [No Abstract]   [Full Text] [Related]  

  • 6. [Not Available].
    Nau JY
    Rev Med Suisse; 2020 Jun; 16(696):1174-1175. PubMed ID: 32496708
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical considerations for managing dermatology patients on systemic immunosuppressive or biologic therapy, or both, during the COVID-19 pandemic.
    Sanchez DP; Kirsner RS; Lev-Tov H
    J Am Acad Dermatol; 2020 Jul; 83(1):288-292. PubMed ID: 32380214
    [No Abstract]   [Full Text] [Related]  

  • 8. Keeping track of the SARS-CoV-2 vaccine pipeline.
    Parker EPK; Shrotri M; Kampmann B
    Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 vaccine trials: Duty of care and standard of prevention considerations.
    Singh JA
    Vaccine; 2020 Nov; 38(48):7578-7580. PubMed ID: 33069443
    [No Abstract]   [Full Text] [Related]  

  • 10. Will bacille Calmette-Guerin immunization arrest the COVID-19 pandemic?
    Ehtesham NZ; Samal J; Ahmad F; Arish M; Naz F; Alam A; Agrawal U; Hasnain SE
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):16-20. PubMed ID: 32859863
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunotherapy is a preferred option for oral cancer patients during COVID-19 pandemic?
    Chu C; Sun Y; Pan Y
    Oral Oncol; 2020 Aug; 107():104860. PubMed ID: 32571643
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclosporine therapy during the COVID-19 pandemic.
    Rudnicka L; Glowacka P; Goldust M; Sikora M; Sar-Pomian M; Rakowska A; Samochocki Z; Olszewska M
    J Am Acad Dermatol; 2020 Aug; 83(2):e151-e152. PubMed ID: 32376422
    [No Abstract]   [Full Text] [Related]  

  • 13. Coronavirus and Patients With Inflammatory Bowel Disease: Management Strategies for the Practicing Clinician.
    Lichtenstein GR; Rubin DT
    Am J Gastroenterol; 2020 Oct; 115(10):1566-1569. PubMed ID: 32833732
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 in Children with Nephrotic Syndrome on Anti-CD20 Chronic Immunosuppression.
    Angeletti A; Drovandi S; Sanguineri F; Santaniello M; Ferrando G; Forno R; Cipresso G; Caridi G; Riella LV; Cravedi P; Ghiggeri GM
    Clin J Am Soc Nephrol; 2020 Oct; 15(10):1494-1495. PubMed ID: 32718953
    [No Abstract]   [Full Text] [Related]  

  • 15. Advances in skin science enable the development of a COVID-19 vaccine.
    Falo LD
    J Am Acad Dermatol; 2020 Oct; 83(4):1226-1227. PubMed ID: 32485211
    [No Abstract]   [Full Text] [Related]  

  • 16. The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway-inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic.
    Wan MT; Shin DB; Winthrop KL; Gelfand JM
    J Am Acad Dermatol; 2020 Aug; 83(2):677-679. PubMed ID: 32416207
    [No Abstract]   [Full Text] [Related]  

  • 17. Moderate-to-severe hidradenitis suppurativa under systemic therapy during the COVID-19 outbreak.
    Rozzo G; Ramondetta A; Fierro MT; Dapavo P; Ribero S
    Dermatol Ther; 2020 Jul; 33(4):e13680. PubMed ID: 32447800
    [No Abstract]   [Full Text] [Related]  

  • 18. Developing Covid-19 Vaccines at Pandemic Speed.
    Lurie N; Saville M; Hatchett R; Halton J
    N Engl J Med; 2020 May; 382(21):1969-1973. PubMed ID: 32227757
    [No Abstract]   [Full Text] [Related]  

  • 19. The Race to Develop a COVID-19 Vaccine.
    Am J Nurs; 2020 Oct; 120(10):14-15. PubMed ID: 32976132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Early Days: The Postkidney Transplant Recipients' COVID-19 Journey.
    Roberts GV; Gee PO
    Clin J Am Soc Nephrol; 2020 Sep; 15(9):1221-1223. PubMed ID: 32727854
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.